ABSI - Absci Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.40
DETAILS
HIGH:
$16.00
LOW:
$9.00
MEDIAN:
$12.00
CONSENSUS:
$12.40
UPSIDE:
16.98%
About Absci Corporation (https://www.absci.com)
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Sean McClain | Founder, Chief Executive Officer, President & Director | 1990 | $1,076,501 USD |
| Zachariah Jonasson | Chief Business Officer & Chief Financial Officer | 1973 | $816,507 USD |
| Alexander Khan | CVP of Finance & Head of Investor Relations | – | – |
| Amer-Denis Akkad | Vice President of Research | – | – |
| Amir Shanehsazzadeh | Chief AI Officer | – | – |
| Christine Lemke | Senior Vice President of Portfolio & Growth Strategy | – | – |
| Jeanne Schreuder SPHR | Senior Vice President of People & Experience | – | – |
| Ransi Somaratne FACC | Chief Medical Officer | 1966 | – |
| Shelby Walker | Chief Legal Officer | 1975 | – |
| Todd Bedrick | Senior Vice President & Chief Accounting Officer | – | – |
| Wen Sha | Chief of Staff | – | – |